New resolution allows planting by universities and pharmaceutical industries, requiring maximum security systems and total traceability of the plant

Amidst the expansion of the medical market, regulatory tensions, and the entry of emerging countries like Brazil, the conference establishes itself as a strategic space for scenario analysis, political articulation, and global business

Letter brings together experts from across the country and includes UFLA participation

The historic investment from the Financier of Studies and Projects (Finep) will finance cutting-edge structures in two regions of the country. The approval, combined with recent authorizations from Anvisa, boosts the development of the scientific bases of the "CBD Brazil" project with the central goal of reducing the costs of medicinal products in Brazil, subsidizing the national production chain

Experts analyze the scenario and highlight that the measure meets Anvisa's expectations for the Brazilian market; Analysis reveals that the new legislation does not represent prohibition, but rather a restructuring of the sector focusing on taxation and pharmaceutical control

Event in São Paulo brings together regulators and experts to discuss regulation, cultivation, and the market landscape of the sector

Paulo Pereira launches Cannabis Global Co., a book that analyzes cannabis capitalism and the contradictions of cannabis legalization worldwide

Event gathered over 40 doctors and marked the beginning of the partnership between Sampa Cannabis and Santa Cannabis to expand access to cannabinoid medicine in Brazil

“Now is the time to devise strategies and discuss how to implement and improve the requirements that will come,” says Beatriz Marti Emygdio, researcher at Embrapa and president of the Permanent Committee on Cannabis (CPCAN)

Debates on medicinal cannabis continue deeply at Cannabis Connection 2025 in November and at the Brazilian Medicinal Cannabis Congress in May 2026, both in São Paulo.

Studies show efficacy of cannabinoids in controlling inflammation, acne, and itching, while Anvisa evaluates expanding regulations for topical products

From folk medicine to modern studies, the plant reveals its healing strength guided by the hands and knowledge of women

Document developed by a group with 31 Brazilian academic and research institutions points out regulatory barriers and suggests an agile framework to strengthen the scientific and technological sector

A research by the Federal University of Latin American Integration (UNILA), conducted in partnership with the Santa Cannabis association, will grace the pages of the renowned scientific journal Frontiers in Pharmacology

General coordinator details the efforts made by the public agency

Patients who rely on medicinal cannabis face legal battles and, in many cases, imprisonment. Understand the challenges of access, the legal impacts, and the stories of those fighting for the right to treatment in Brazil.

Ongoing research seeks to find solutions to the problems of large-scale cannabis plantations

Study points to an association between cannabis consumption and a lower risk of kidney stones in male users

State deputies present proposal to offer therapeutic treatment based on cannabidiol to patients in vulnerable situations

Historical use of medicinal cannabis is highlighted at the launch ceremony